Literature DB >> 8095626

Reliability of polymerase chain reaction for detection of hepatitis C virus.

H L Zaaijer1, H T Cuypers, H W Reesink, I N Winkel, G Gerken, P N Lelie.   

Abstract

The polymerase chain reaction (PCR) is used to detect hepatitis C virus (HCV) RNA, and the results of this assay may have a bearing on management of patients. We tested 31 laboratories for performance of HCV PCR with a coded panel that comprised 4 HCV-positive plasma samples, 6 HCV-negative samples, and two dilution series of HCV-positive plasma. 15 (48%) laboratories had faultless results with both dilution series, and 16 (52%) laboratories reported erroneous results with one or both series. 10 (32%) laboratories had faultless results when testing undiluted plasma samples, 11 (35%) produced a false-negative result with a weak-positive sample, and 10 (32%) produced false negative and/or false positive results. Only 5 (16%) laboratories performed faultlessly with the entire panel of samples. Reports of presence of HCV should be interpreted with care until reliable HCV-RNA detection becomes widely available.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095626     DOI: 10.1016/0140-6736(93)90488-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  76 in total

1.  Multicenter quality assessment of PCR methods for detection of enteroviruses.

Authors:  P Muir; A Ras; P E Klapper; G M Cleator; K Korn; C Aepinus; A Fomsgaard; P Palmer; A Samuelsson; A Tenorio; B Weissbrich; A M van Loon
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  Performance of the COBAS AMPLICOR HCV MONITOR test, version 2.0, an automated reverse transcription-PCR quantitative system for hepatitis C virus load determination.

Authors:  G Gerken; T Rothaar; M G Rumi; R Soffredini; M Trippler; M J Blunk; A Butcher; S Soviero; G Colucci
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  A multicenter study evaluation of the digene hybrid capture II signal amplification technique for detection of hepatitis B virus DNA in serum samples and testing of EUROHEP standards.

Authors:  H G Niesters; M Krajden; L Cork; M de Medina; M Hill; E Fries; A D Osterhaus
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

4.  Hepatitis C virus quantitation: optimization of strategies for detecting low-level viremia.

Authors:  W T Hofgärtner; J A Kant; K E Weck
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 5.  False-positive results and contamination in nucleic acid amplification assays: suggestions for a prevent and destroy strategy.

Authors:  A Borst; A T A Box; A C Fluit
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-10       Impact factor: 3.267

6.  Hepatitis C: Recent advances.

Authors:  S D Shafran; J M Conly
Journal:  Can J Infect Dis       Date:  1993-07

7.  Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR.

Authors:  S Bretagne; J M Costa; A Marmorat-Khuong; F Poron; C Cordonnier; M Vidaud; J Fleury-Feith
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

8.  Detection of hepatitis C virus RNA by a combined reverse transcription PCR assay: comparison with nested amplification and antibody testing.

Authors:  K K Young; J J Archer; O Yokosuka; M Omata; R M Resnick
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

9.  Reliability of nucleic acid amplification methods for detection of Chlamydia trachomatis in urine: results of the first international collaborative quality control study among 96 laboratories.

Authors:  Roel P Verkooyen; Gerda T Noordhoek; Paul E Klapper; Jim Reid; Jurjen Schirm; Graham M Cleator; Margareta Ieven; Gunnar Hoddevik
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Hepatitis C virus infections in dialysis centers in The Netherlands: a national survey by serological and molecular methods.

Authors:  P M Schneeberger; I Keur; W van der Vliet; K van Hoek; H Boswijk; A M van Loon; W C van Dijk; R H Kauffmann; W Quint; L J van Doorn
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.